Join this webinar to hear from Afortori Development and Pym’s Consultancy, on tips and advice for ensuring your Clinical Trial helps you to sell your products.
The reason for conducting trials is to validate your product or service so that you can enter the market or increase sales.
Before you start planning your trial you need to establish what your long term goals are, and then how evidence and validation will help you reach those goals. In this way your research and development strategy is embedded into your overall business strategy – in short every element of your business complements the others and your company has a clear road map for the future helping you to maximise your return on investment in all parts of the business.
In the sales process a successful trial starts as a talking point, delivers evidence to support your sales pitch, and validates your product to the wider NHS environment, broadening your reach into the market.
Attend to learn about the above and take the opportunity to get your questions answered by the experts.
DURATION: 1 hour
This free to attend event is held as part of the SoLSTICE programme – a project part-funded by the European Regional Development Fund, click here to be re-directed to further information about the project. This event is classed as State Aid to participating businesses, the value of which is £127, but is delivered completely free of charge to participants.
Speaker Profiles:
Dr Nicola Wall, Chief Executive Officer, Afortori Development
Nicola Wall , along with Elizabeth Ralph founded Afortiori Development after long careers in clinical research within a variety of roles. Both bring a commitment to well designed and successfully executed clinical trials.
Kate Pym, Managing Director, Pym’s Consultancy
Kate Pym is Managing Director of Pym’s Consultancy Ltd, an independent consultancy providing services for SMEs and universities supporting grant applications, responses to tender and commercialisation
Kate has over 20 years’ experience of working in Health and Social Care for companies, including Allergan Inc., AstraZeneca, Mitie and Baxter Healthcare. With a focus on innovative products and services. She has worked across the NHS, public, private and third sectors to produce patient-centred, high quality, outcome based services and facilitate the market entry and growth of new products.
Kate’s experience covers: Product launches, writing winning bids, working with commissioners to model population outcomes, designing, selling and mobilization of new integrated services. She has a clear focus on outcomes and what is required to demonstrate them, with a view to extension and expansion of constructive innovation. Since 2014 Kate has supported over 40 organisations as managing director of Pym’s.
